Biochemical Markers of Colorectal Cancer – Present and Future

Wojciech Jelski,1 Barbara Mroczko1,2 1Department of Biochemical Diagnostics, Medical University of Bialystok, Bialystok, Poland; 2Department of Neurodegeneration Diagnostics, Medical University of Bialystok, Bialystok, PolandCorrespondence: Wojciech JelskiDepartment of Biochemical Diagnostics, Medic...

Full description

Bibliographic Details
Main Authors: Jelski W, Mroczko B
Format: Article
Language:English
Published: Dove Medical Press 2020-06-01
Series:Cancer Management and Research
Subjects:
Online Access:https://www.dovepress.com/biochemical-markers-of-colorectal-cancer-ndash-present-and-future-peer-reviewed-article-CMAR
_version_ 1819065434675085312
author Jelski W
Mroczko B
author_facet Jelski W
Mroczko B
author_sort Jelski W
collection DOAJ
description Wojciech Jelski,1 Barbara Mroczko1,2 1Department of Biochemical Diagnostics, Medical University of Bialystok, Bialystok, Poland; 2Department of Neurodegeneration Diagnostics, Medical University of Bialystok, Bialystok, PolandCorrespondence: Wojciech JelskiDepartment of Biochemical Diagnostics, Medical University of Bialystok, Waszyngtona 15 A, Bialystok 15– 269, PolandTel +48 85 746 8587Fax +48 85 746 8585Email wjelski@umb.edu.plAbstract: According to a report by the National Cancer Institute, colorectal cancer (CRC) is one of the most common types of cancer worldwide. CRC is often recognized too late for successful therapy. Tumor markers have been sought for a number of years to detect the transformation of malignant cells at the earliest possible stage. They are usually proteins associated with a malignancy and might be clinically useful in patients with cancer. Several classical markers have been used to recognize colorectal cancer, including carcinoembryonic antigen (CEA), carbohydrate antigen (CA 19.9), tissue polypeptide specific antigen (TPS) and tumor-associated glycoprotein-72 (TAG-72). None of these tests, however, have excellent diagnostic accuracy. Recent studies have been conducted on the use of hematopoietic growth factors (HGFs) and various enzymes in the diagnosis and prognosis of colorectal cancer. These include macrophage-colony stimulating factor (M-CSF) and granulocyte-macrophage-colony stimulating factor (GM-CSF), interleukin-3, interleukin-6 and enzymes (alcohol dehydrogenase and lysosomal exoglycosidases). Significantly, most cancer deaths are not caused by the primary tumor itself but by its spread. Analysis of circulating cancer cells (CTCs), ie, factors responsible for metastasis, may be a source of information useful in the treatment of patients with colorectal cancer. Currently available markers have significant limitations.Keywords: tumor markers, colorectal cancer
first_indexed 2024-12-21T15:46:24Z
format Article
id doaj.art-3dd1f3954c0a42cfb97cc9ef2d0f51fc
institution Directory Open Access Journal
issn 1179-1322
language English
last_indexed 2024-12-21T15:46:24Z
publishDate 2020-06-01
publisher Dove Medical Press
record_format Article
series Cancer Management and Research
spelling doaj.art-3dd1f3954c0a42cfb97cc9ef2d0f51fc2022-12-21T18:58:20ZengDove Medical PressCancer Management and Research1179-13222020-06-01Volume 124789479754715Biochemical Markers of Colorectal Cancer – Present and FutureJelski WMroczko BWojciech Jelski,1 Barbara Mroczko1,2 1Department of Biochemical Diagnostics, Medical University of Bialystok, Bialystok, Poland; 2Department of Neurodegeneration Diagnostics, Medical University of Bialystok, Bialystok, PolandCorrespondence: Wojciech JelskiDepartment of Biochemical Diagnostics, Medical University of Bialystok, Waszyngtona 15 A, Bialystok 15– 269, PolandTel +48 85 746 8587Fax +48 85 746 8585Email wjelski@umb.edu.plAbstract: According to a report by the National Cancer Institute, colorectal cancer (CRC) is one of the most common types of cancer worldwide. CRC is often recognized too late for successful therapy. Tumor markers have been sought for a number of years to detect the transformation of malignant cells at the earliest possible stage. They are usually proteins associated with a malignancy and might be clinically useful in patients with cancer. Several classical markers have been used to recognize colorectal cancer, including carcinoembryonic antigen (CEA), carbohydrate antigen (CA 19.9), tissue polypeptide specific antigen (TPS) and tumor-associated glycoprotein-72 (TAG-72). None of these tests, however, have excellent diagnostic accuracy. Recent studies have been conducted on the use of hematopoietic growth factors (HGFs) and various enzymes in the diagnosis and prognosis of colorectal cancer. These include macrophage-colony stimulating factor (M-CSF) and granulocyte-macrophage-colony stimulating factor (GM-CSF), interleukin-3, interleukin-6 and enzymes (alcohol dehydrogenase and lysosomal exoglycosidases). Significantly, most cancer deaths are not caused by the primary tumor itself but by its spread. Analysis of circulating cancer cells (CTCs), ie, factors responsible for metastasis, may be a source of information useful in the treatment of patients with colorectal cancer. Currently available markers have significant limitations.Keywords: tumor markers, colorectal cancerhttps://www.dovepress.com/biochemical-markers-of-colorectal-cancer-ndash-present-and-future-peer-reviewed-article-CMARtumor markerscolorectal cancer
spellingShingle Jelski W
Mroczko B
Biochemical Markers of Colorectal Cancer – Present and Future
Cancer Management and Research
tumor markers
colorectal cancer
title Biochemical Markers of Colorectal Cancer – Present and Future
title_full Biochemical Markers of Colorectal Cancer – Present and Future
title_fullStr Biochemical Markers of Colorectal Cancer – Present and Future
title_full_unstemmed Biochemical Markers of Colorectal Cancer – Present and Future
title_short Biochemical Markers of Colorectal Cancer – Present and Future
title_sort biochemical markers of colorectal cancer ndash present and future
topic tumor markers
colorectal cancer
url https://www.dovepress.com/biochemical-markers-of-colorectal-cancer-ndash-present-and-future-peer-reviewed-article-CMAR
work_keys_str_mv AT jelskiw biochemicalmarkersofcolorectalcancerndashpresentandfuture
AT mroczkob biochemicalmarkersofcolorectalcancerndashpresentandfuture